Recruiting × Triple Negative Breast Neoplasms × Genitourinary × Clear all A Study of BMS-986340 as Monotherapy and in Combination With Nivolumab or Docetaxel in Participants With Advanced Solid Tumors
Phase 1/2 Recruiting
949 enrolled
SELECT-2CAR
Phase 1/2 Recruiting
72 enrolled
Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors
Phase 1 Recruiting
40 enrolled
This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors
Phase 1 Recruiting
100 enrolled
NEXUS-01
Phase 1 Recruiting
420 enrolled
Access to Genetic Testing in Underserved Patients With Cancer
Phase NA Recruiting
800 enrolled
A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
Phase 1/2 Recruiting
60 enrolled
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Phase 1/2 Recruiting
300 enrolled
PNeoVCA
Phase 1/2 Recruiting
132 enrolled
A Study to Learn About Study Medicine ALTA2618 in Adults With AKT1 E17K-Mutant Solid Tumors
Phase 1 Recruiting
110 enrolled
A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors
Phase 1 Recruiting
258 enrolled
TTX-080 HLA-G Antagonist in Subjects With Advanced Cancers
Phase 1 Recruiting
240 enrolled
BASECAMP-1
Recruiting
200 enrolled
ELEPHAS-05
Recruiting
2,000 enrolled
A Study to Investigate APL-5125 in Adults With Advanced Solid Tumors
Phase 1/2 Recruiting
100 enrolled
Safety and Tolerability of IPH4502 in Patients With Advanced Solid Tumors
Phase 1 Recruiting
145 enrolled
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
Phase 1 Recruiting
96 enrolled
ON-5001
Phase 1 Recruiting
168 enrolled
TASTY-steering
Phase NA Recruiting
201 enrolled
A Study to Assess Safety, Tolerability and Imaging Characteristics of [68Ga]Ga-DPI-4452 and to Assess Safety, Tolerability, and Efficacy of [177Lu]Lu-DPI-4452 in Participants With Unresectable Locally Advanced or Metastatic Solid Tumors
Phase 1/2 Recruiting
270 enrolled
Study of JANX008 in Subjects With Advanced or Metastatic Solid Tumor Malignancies
Phase 1 Recruiting
130 enrolled
Phase 1/2 Clinical Trial of CP-506 (HAP) in Monotherapy or With Carboplatin or ICI
Phase 1/2 Recruiting
126 enrolled
AGADIR
Phase 2 Recruiting
247 enrolled
ModiFY
Phase 1/2 Recruiting
168 enrolled
A Study of NX-1607 in Adults With Advanced Malignancies
Phase 1 Recruiting
345 enrolled
DENALI-1
Phase 1/2 Recruiting
240 enrolled
ABILITY-1
Phase 1/2 Recruiting
115 enrolled
MOIO
Phase 3 Recruiting
646 enrolled
Diagnostic Efficacy and Dosimetry of MNPR-101-DFO*-89Zr in Patients With Solid Tumors
Phase 1 Recruiting
12 enrolled
Dose-Escalation of MNPR-101-PCTA-177Lu in Solid Tumors
Phase 1 Recruiting
12 enrolled
A Multicenter Cancer Biospecimen Collection Study
Recruiting
1,650 enrolled
Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067
Phase 1/2 Recruiting
316 enrolled
PARADIGM
Recruiting
800 enrolled